Immunocryosurgery for Treatment of Locally Advanced BCC: A Case Report

BCC is the most common skin cancer (75%) in humans and the most common malignant tumor in the Caucasian population. The literature recognizes that 95% of BCCs are easy to treat surgically; however, when surgery is contraindicated due to patient or lesion-related conditions pharmacological and destructive therapies are reasonable alternatives. New therapeutic modalities, such as combined therapy, have been proven successful in the treatment of locally advanced and difficult-to-treat BCCs.